PTC Taps Genzyme’s Global Reach, Pocketbook In Ultra-orphan Licensing Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
PTC124 offers new approach for treating lysosomal storage disorders central to Genzyme’s success, as well as other genetic diseases.